EpiVax is closer to clinical trials for vaccines

DR. CHRISTINE MALBOEUF samples different mediums at EpiVax, a Providence biotech firm that is using computerized gene sequencing to help develop vaccines. /
DR. CHRISTINE MALBOEUF samples different mediums at EpiVax, a Providence biotech firm that is using computerized gene sequencing to help develop vaccines. /
Having spent the first part of its history developing a closely guarded technology platform that drives its work, a Providence company is working to develop vaccines for HIV, smallpox, tularemia, and other infectious diseases and potential bioterrorist weapons. EpiVax Inc. was founded in 1998 by Dr. Anne S. De Groot, an associate professor of community…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -